Health Care & Life Sciences » Biotechnology | Ampliphi Biosciences Corp.

Ampliphi Biosciences Corp.

Ampliphi Biosciences Corp.
Stock Exchange NYSE
EPS
$0.74
Market Cap
$15.89 M
Shares Outstanding
16.46 M
Public Float
15.59 M

Profile

Address
3579 Valley Centre Drive
San Diego California 92130
United States
Employees -
Website http://www.ampliphibio.com
Updated 09/14/2018
AmpliPhi Biosciences Corp. operates as a biopharmaceutical company. It engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company was founded in March 1989 and is headquartered in San Diego, CA.

Financials

View All

Paul C. Grint
Chief Executive Officer & Director
Wendy S. Johnson
Director